LTR Pharma Limited Stock: price and insider trades · Australia

LTR Pharma Limited is a listed company. Its insiders report their share dealings to ASX. In the past year (6 November 2025 to 6 November 2026), 3 filings came from 3 insiders.

Not one open-market sale was filed. On the buying side, 2 insiders reported 2 purchases. The totals do not cover 2 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 2 senior executives.

For context, the typical company on the same exchange (median of 1,626 companies) published 5 filings over the same period, against 3 filings here. Since 2026, the database holds 2 purchases and no sales by insiders of the company.

The last purchase on record was published on 6 November 2026, which is 2 days ago. Typically, a trade is published a median of 2 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done.

This summary is built from ASX disclosures alone and does not predict where the share price will go.